Skip to content

Opening book details…

Can I read Repurposing the antiamoebic drug diiodohydroxyquinoline for treatment of Clostridioides difficile infections on EtoBox?

Repurposing the antiamoebic drug diiodohydroxyquinoline for treatment of Clostridioides difficile infections by Abutaleb, Nader S.; Seleem, Mohamed N. is a Medicine article available to read on EtoBox.

What is Repurposing the antiamoebic drug diiodohydroxyquinoline for treatment of Clostridioides difficile infections about?

Clostridioides difficile , the leading cause of nosocomial infections, is an urgent health threat worldwide. The increased incidence and severity of disease, the high recurrence rates, and the dearth of effective anticlostridial drugs have created an urgent need for new therapeutic agents. In an effort to discover new drugs for the treatment of Clostridioides difficile infections (CDIs), we investigated a panel of FDA-approved antiparasitic drugs against C. difficile and identified diiodohydroxyquinoline (DIHQ), an FDA-approved oral antiamoebic drug.

Who reads Repurposing the antiamoebic drug diiodohydroxyquinoline for treatment of Clostridioides difficile infections?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Abutaleb, Nader S.; Seleem, Mohamed N.
Publisher
American Society for Microbiology (ISSN 0066-4804)
Published
2020
Language
EN
Field
Medicine (Health Sciences)

More by Abutaleb, Nader S.; Seleem, Mohamed N.

Browse all works by Abutaleb, Nader S.; Seleem, Mohamed N.